{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:30:38Z","timestamp":1771993838268,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11845-021-02651-x","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T05:02:43Z","timestamp":1621227763000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"191","author":[{"given":"Han","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingya","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2193-9266","authenticated-orcid":false,"given":"Muhammad","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Kaiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingxi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"issue":"20","key":"2651_CR1","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.1986.03380200061022","volume":"256","author":"J Stamler","year":"1986","unstructured":"Stamler J, Wentworth D, Neaton JD (1986) Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256(20):2823\u20132828","journal-title":"JAMA"},{"issue":"8A","key":"2651_CR2","doi-asserted-by":"publisher","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","volume":"97","author":"M Law","year":"2006","unstructured":"Law M, Rudnicka AR (2006) Statin safety: a systematic review. Am J Cardiol 97(8A):52C-60C","journal-title":"Am J Cardiol"},{"issue":"6","key":"2651_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10557-005-6352-1","volume":"19","author":"A Corsini","year":"2005","unstructured":"Corsini A (2005) Statin-related muscle complaints: an underestimated risk. Cardiovasc Drugs Ther 19(6):379\u2013381","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"2651_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0022-2275(20)41990-X","volume":"32","author":"PG Elmberger","year":"1991","unstructured":"Elmberger PG, Kal\u00a8\u00a6n A, Lund E et al (1991) Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. J Lipid Res 32(6):935\u2013940","journal-title":"J Lipid Res"},{"issue":"6","key":"2651_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","volume":"20","author":"FL Crane","year":"2001","unstructured":"Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20(6):591\u2013598","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"2651_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","volume":"33","author":"G Ghirlanda","year":"1993","unstructured":"Ghirlanda G, Oradei A, Manto A et al (1993) Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol 33(3):226\u2013229","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2651_CR7","first-page":"483","volume":"2","author":"A Thibault","year":"1996","unstructured":"Thibault A, Samid D, Tompkins AC et al (1996) Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2(3):483\u2013491","journal-title":"Clin Cancer Res"},{"issue":"supplement","key":"2651_CR8","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1016\/S0098-2997(97)00014-9","volume":"18","author":"SA Mortensen","year":"1997","unstructured":"Mortensen SA, Leth A, Agner E, Rohde M (1997) Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med 18(supplement):S137-144","journal-title":"Mol Aspects Med"},{"issue":"4","key":"2651_CR9","first-page":"324","volume":"49","author":"Y Miyake","year":"1999","unstructured":"Miyake Y, Shouzu A, Nishikawa M et al (1999) Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneimittelforschung 49(4):324\u2013329","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"2651_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/archneur.61.6.889","volume":"61","author":"T Rundek","year":"2004","unstructured":"Rundek T, Naini A, Sacco R et al (2004) Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 61(6):889\u2013892","journal-title":"Arch Neurol"},{"issue":"2","key":"2651_CR11","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.atherosclerosis.2007.06.010","volume":"195","author":"H Mabuchi","year":"2007","unstructured":"Mabuchi H, Nohara A, Kobayashi J et al (2007) Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis 195(2):e182-189","journal-title":"Atherosclerosis"},{"issue":"supplement","key":"2651_CR12","doi-asserted-by":"publisher","first-page":"s187","DOI":"10.1016\/0098-2997(94)90028-0","volume":"15","author":"AM Bargossi","year":"1994","unstructured":"Bargossi AM, Grossi G, Fiorella PL et al (1994) Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. Mol Aspects Med 15(supplement):s187-193","journal-title":"Mol Aspects Med"},{"issue":"10","key":"2651_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","volume":"99","author":"G Caso","year":"2007","unstructured":"Caso G, Kelly P, McNurlan MA, Lawson WE (2007) Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 99(10):1409\u20131412","journal-title":"Am J Cardiol"},{"issue":"9","key":"2651_CR14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","volume":"100","author":"JM Young","year":"2007","unstructured":"Young JM, Florkowski CM, Molyneux SL et al (2007) Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol 100(9):1400\u20131403","journal-title":"Am J Cardiol"},{"key":"2651_CR15","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"2651_CR16","doi-asserted-by":"crossref","unstructured":"Higgins\u00a0JP,\u00a0Altman DG,\u00a0G?tzsche PC et al (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343:d5928","DOI":"10.1136\/bmj.d5928"},{"key":"2651_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135","journal-title":"BMC Med Res Methodol"},{"key":"2651_CR18","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.2147\/DDDT.S223153","volume":"13","author":"G Derosa","year":"2019","unstructured":"Derosa G, D\u2019Angelo A, Maffioli P (2019) Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study. Drug Des Devel Ther 13:3647\u20133655","journal-title":"Drug Des Devel Ther"},{"key":"2651_CR19","doi-asserted-by":"crossref","unstructured":"Fedacko\u00a0J,\u00a0Pella D,\u00a0Fedackova P et al\u00a0(2013) Coenzyme Q(10) and selenium in statin-associated myopathy treatment. Can J Physiol Pharmacol 91(2):165\u2013170","DOI":"10.1139\/cjpp-2012-0118"},{"issue":"4","key":"2651_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.amjcard.2012.04.026","volume":"110","author":"DA Bookstaver","year":"2012","unstructured":"Bookstaver DA, Burkhalter NA, Hatzigeorgiou C (2012) Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am J Cardiol 110(4):526\u2013529","journal-title":"Am J Cardiol"},{"issue":"2","key":"2651_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.12.016","volume":"238","author":"BA Taylor","year":"2015","unstructured":"Taylor BA, Lorson L, White CM, Thompson PD (2015) A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis 238(2):329\u2013335","journal-title":"Atherosclerosis"},{"key":"2651_CR22","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.12659\/MSM.890777","volume":"20","author":"A Skarlovnik","year":"2014","unstructured":"Skarlovnik A, Jani M, Lunder M et al (2014) Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit 20:2183\u20132188","journal-title":"Med Sci Monit"},{"issue":"3","key":"2651_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1535370215605588","volume":"241","author":"SL Pek","year":"2016","unstructured":"Pek SL, Tavintharan S, Woon K et al (2016) MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation. Exp Biol Med (Maywood) 241(3):317\u2013330","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2651_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mayocp.2014.08.021","volume":"90","author":"M Banach","year":"2015","unstructured":"Banach M, Serban C, Sahebkar A et al (2015) Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc 90(1):24\u201334","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"2651_CR25","doi-asserted-by":"publisher","first-page":"e009835","DOI":"10.1161\/JAHA.118.009835","volume":"7","author":"H Qu","year":"2018","unstructured":"Qu H, Guo M, Chai H et al (2018) Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc 7(19):e009835","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"2651_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A et al (2015) Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment. Aetiology and Management Eur Heart J 36(17):1012\u20131022. https:\/\/doi.org\/10.1093\/eurheartj\/ehv043","journal-title":"Aetiology and Management Eur Heart J"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-021-02651-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:15:22Z","timestamp":1649204122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-021-02651-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2651"],"URL":"https:\/\/doi.org\/10.1007\/s11845-021-02651-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}